308 related articles for article (PubMed ID: 15947432)
1. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung.
Sriramulu DD; Lünsdorf H; Lam JS; Römling U
J Med Microbiol; 2005 Jul; 54(Pt 7):667-676. PubMed ID: 15947432
[TBL] [Abstract][Full Text] [Related]
2. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
Davies EV; James CE; Brockhurst MA; Winstanley C
BMC Microbiol; 2017 Jan; 17(1):3. PubMed ID: 28056789
[TBL] [Abstract][Full Text] [Related]
4. Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung.
Dingemans J; Monsieurs P; Yu SH; Crabbé A; Förstner KU; Malfroot A; Cornelis P; Van Houdt R
mBio; 2016 Aug; 7(4):. PubMed ID: 27486191
[TBL] [Abstract][Full Text] [Related]
5. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
[TBL] [Abstract][Full Text] [Related]
6. Sputum containing zinc enhances carbapenem resistance, biofilm formation and virulence of Pseudomonas aeruginosa.
Marguerettaz M; Dieppois G; Que YA; Ducret V; Zuchuat S; Perron K
Microb Pathog; 2014 Dec; 77():36-41. PubMed ID: 25448466
[TBL] [Abstract][Full Text] [Related]
7. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
Singh PK; Schaefer AL; Parsek MR; Moninger TO; Welsh MJ; Greenberg EP
Nature; 2000 Oct; 407(6805):762-4. PubMed ID: 11048725
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
Sousa AM; Monteiro R; Pereira MO
Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
[TBL] [Abstract][Full Text] [Related]
9. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
Evans TJ
Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
[TBL] [Abstract][Full Text] [Related]
10. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease.
Thomas SR; Ray A; Hodson ME; Pitt TL
Thorax; 2000 Sep; 55(9):795-7. PubMed ID: 10950901
[TBL] [Abstract][Full Text] [Related]
11. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.
Palmer KL; Aye LM; Whiteley M
J Bacteriol; 2007 Nov; 189(22):8079-87. PubMed ID: 17873029
[TBL] [Abstract][Full Text] [Related]
12.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
13. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.
Turner KH; Wessel AK; Palmer GC; Murray JL; Whiteley M
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4110-5. PubMed ID: 25775563
[TBL] [Abstract][Full Text] [Related]
14. Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill
Sweeney E; Sabnis A; Edwards AM; Harrison F
Microbiology (Reading); 2020 Dec; 166(12):1171-1180. PubMed ID: 33253080
[No Abstract] [Full Text] [Related]
15. Diagnosis of biofilm infections in cystic fibrosis patients.
Høiby N; Bjarnsholt T; Moser C; Jensen PØ; Kolpen M; Qvist T; Aanaes K; Pressler T; Skov M; Ciofu O
APMIS; 2017 Apr; 125(4):339-343. PubMed ID: 28407432
[TBL] [Abstract][Full Text] [Related]
16. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
Fernández-Barat L; Ciofu O; Kragh KN; Pressler T; Johansen U; Motos A; Torres A; Hoiby N
J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
[TBL] [Abstract][Full Text] [Related]
18. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
[TBL] [Abstract][Full Text] [Related]
19. Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients.
Barthe C; Nandakumar S; Derlich L; Macey J; Bui S; Fayon M; Crouzet M; Garbay B; Vilain S; Costaglioli P
Lett Appl Microbiol; 2015 Nov; 61(5):423-8. PubMed ID: 26174137
[TBL] [Abstract][Full Text] [Related]
20. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Hogardt M; Heesemann J
Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]